The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...
Hosted on MSN51m
New type of non-opioid pain medication approved by FDAThe U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback